- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 319/20 - 1,4-DioxanesHydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Patent holdings for IPC class C07D 319/20
Total number of patents in this class: 133
10-year publication summary
12
|
2
|
3
|
8
|
5
|
9
|
5
|
6
|
3
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bristol-myers Squibb Company | 4880 |
9 |
Janssen Pharmaceutica N.V. | 3394 |
8 |
Abbvie Inc. | 1800 |
6 |
Calico Life Sciences LLC | 96 |
6 |
Boehringer Ingelheim International GmbH | 4642 |
4 |
Ohio University | 366 |
4 |
Alkahest, Inc. | 95 |
3 |
KYORIN Pharmaceutical Co., Ltd. | 167 |
3 |
New York University | 1751 |
3 |
Nisshin Pharma Inc. | 36 |
3 |
Ottawa Hospital Research Institute | 108 |
3 |
Oxford University Innovation Limited | 1537 |
3 |
The Research Foundation for The State University of New York | 1621 |
3 |
Taisho Pharmaceutical Co., Ltd. | 875 |
3 |
Toyama Chemical Co., Ltd. | 102 |
3 |
vTv Therapeutics LLC | 151 |
3 |
Wyeth | 361 |
3 |
Henkel AG & Co. KGaA | 10583 |
2 |
Antabio SAS | 22 |
2 |
The Trustees of Princeton University | 1199 |
2 |
Other owners | 57 |